title: The current status of imaging in anti-NGF clinical trials.
authors.affiliation: Medical Affairs, BioClinica, Newtown, PA, USA. Electronic address: colin.miller@bioclinica.com.
authors.forename: C G
authors.initials: CG
authors.lastname: Miller
authors.affiliation: Quantitative Imaging Center (QIC), Department of Radiology, Boston University School of Medicine, Boston, MA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Guermazi
authors.affiliation: Department of Radiology, University of Erlangen-Nuremberg, Erlangen, Germany.
authors.forename: F
authors.initials: F
authors.lastname: Roemer
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects; D002986:Clinical Trials as Topic; D006801:Humans; D007592:Joint Diseases / Q000139:chemically induced / Q000000981:diagnostic imaging; D020932:Nerve Growth Factor / Q000037:antagonists & inhibitors*; D010003:Osteoarthritis / Q000188:drug therapy; D011859:Radiography
chemical_list: D000911:Antibodies, Monoclonal; D020932:Nerve Growth Factor
keywords: Anti-NGF; Anti-nerve growth factor; Clinical trials; Medical imaging; Radiology; X-ray; aNGF